Invasive Fungal Infections (IFIs) have increasingly become a concern in many parts of
the world. Challenges around early and effective diagnostics as well as shifting
demographic characteristics are among the critical factors driving the increasing threat of
IFIs. The aim of the current study was to estimate the burden of three main IFIs—
Candida infections, Aspergillus infections, and Mucormycosis—in Saudi Arabia. Data
were collected from published government records, research studies directly focusing on
these diseases in Saudi Arabia, and expert advice from healthcare professionals where
some data were completely unavailable to guide the estimation of the burden of disease.
Findings showed that with a total population of slightly above 32 million according to the
government records of 2022, Saudi Arabia’s major burden of the investigated IFIs is
associated with Candida infections. Among 1,568 cases appearing in records used in this
study to inform the burden of disease for Candida infections, it was determined that four
main strains exist, Candida Albicans, Candida tropicalis, Candida glabrata, Candida
parapsilosis, and Candida krusei. C. Albicans presents the highest burden owing to the
many cases (40.11%, n = 629) that emerged from the total cases reported in all cases.
Aspergillus emerged as the second most burdening IFI, with an estimated burden of about
2,445 cases per year, and with the Aspergillus flavu being the most prevalent strain in
Saudi Arabia. Mucormycosis was not a major threat, with the estimated burden of disease
being 109 cases per year for the entire population. Other IFIs reported in the data records
were cryptococcal meningitis, gastrointestinal basidiobolomycosis, and brain abscesses,
but none of these presented any significant burden. The findings show that the highest
burden of IFIs in Saudi Arabia is due to Candida infections and particularly the C.
Albicans strain, with Aspergillus coming closely as the second most burdening condition.
Accordingly, in healthcare planning and resource allocation to address IFIs, there is need
for the government and other relevant stakeholders to focus on enhancing resources for
the diagnosis and treatment of cases of Candida and Aspergillus infections, as these
represent the most significant burden.